Seventeen of America's Most Promising Scientists Selected as 2009 Pew Scholars in the Biomedical Sciences

Navigate to:

Seventeen of America's Most Promising Scientists Selected as 2009 Pew Scholars in the Biomedical Sciences

Philadelphia, PA - The Pew Charitable Trusts today named 17 early-career scientists as Pew Scholars in the Biomedical Sciences. Scholars receive a $240,000 award over four years to help support their work, which this year includes research related to cancer, Parkinson's disease, birth defects and epilepsy. The Scholars also gain inclusion into a select community of scientists that includes Nobel Prize winners, MacArthur Fellows and recipients of the Albert Lasker Medical Research Award.

Now in its 25th year, the Program has invested more than $125 million to fund over 460 scholars.

The selection process for the Pew Scholars is rigorously competitive. Applicants must be nominated by an invited institution and must demonstrate excellence and innovation in their research. This year, 149 institutions were invited to nominate a candidate in basic biomedical research, and 111 eligible nominations were received.

“Pew is thrilled to celebrate 25 successful years for the Biomedical Scholars program,” said Rebecca W. Rimel, President and CEO of The Pew Charitable Trusts. “Not only does the program provide extraordinary scientists with the resources to carry out significant research early in their careers, it also offers them the opportunity to exchange ideas and foster relationships during the annual meetings and various networking activities. These gatherings have often led to collaborations that have resulted in significant scientific progress.”

“The Pew Biomedical Scholars are a synergistic community whose connections are reinforced over the years,” said Craig C. Mello, Ph.D., a 1995 Pew Scholar and a 2006 Nobel laureate in physiology or medicine, and the chair of the national advisory committee for the program. “I have no doubt that this immensely talented and diverse new class of Pew Scholars will have a major impact on biomedical research through their contributions as part of the Pew community and on science as a whole.”

Related Press Release: Ten Top Latin American Scientists Named 2009 Pew Fellows in the Biomedical Sciences

The 2009 Pew Scholars in the Biomedical Sciences are:

Scholar and Institution
Frank Alber, Ph.D. University of Southern California
Diana M. Bautista, Ph.D. University of California, Berkeley
Jon P. Boyle, Ph.D. University of Pittsburgh
Zev D. Bryant, Ph.D. Stanford University
Jennifer G. DeLuca, Ph.D. Colorado State University
Qing R. Fan, Ph.D. Columbia University
Kevin A. Janes, Ph.D. University of Virginia
John K. Kim, Ph.D. University of Michigan
Alexander Meissner, Ph.D. Harvard University
Charles G. Mullighan, M.D. St. Jude Children's Research Hospital
Patrick J. Paddison, Ph.D. Fred Hutchinson Cancer Research Center
Joseph R. Pomerening, Ph.D. Indiana University
Nicholas J. Priebe, Ph.D. University of Texas at Austin
Melissa M. Rolls, Ph.D. The Pennsylvania State University
Joshua W. Shaevitz, Ph.D. Princeton University
Ben Z. Stanger, M.D., Ph.D. University of Pennsylvania
R. Grace Zhai, Ph.D. University of Miami, Miller School of Medicine

America’s Overdose Crisis
America’s Overdose Crisis

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Quick View

America’s Overdose Crisis

Sign up for our five-email course explaining the overdose crisis in America, the state of treatment access, and ways to improve care

Sign up
Composite image of modern city network communication concept

Learn the Basics of Broadband from Our Limited Series

Sign up for our four-week email course on Broadband Basics

Quick View

How does broadband internet reach our homes, phones, and tablets? What kind of infrastructure connects us all together? What are the major barriers to broadband access for American communities?

Pills illustration
Pills illustration

What Is Antibiotic Resistance—and How Can We Fight It?

Sign up for our four-week email series The Race Against Resistance.

Quick View

Antibiotic-resistant bacteria, also known as “superbugs,” are a major threat to modern medicine. But how does resistance work, and what can we do to slow the spread? Read personal stories, expert accounts, and more for the answers to those questions in our four-week email series: Slowing Superbugs.